Calcium and Phosphate Metabolism Flashcards

1
Q
  1. Bone turnover/remodelling serves as a short term service of calcium and phosphate homeostasis, what is this also in conjunction with?
A
  • Parathyroid hormone (PTH)
  • Vitamin D (1,25-dihydroxy D3)
  • Calcitonin

FGF-23

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
  1. What % of body calcium is in the bone?

- Where is the remaining %

A

99%

Remaining 1% is mainly intracellular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
  1. What percentage and amount of calcium is extracellular

- Is this bound (to albumin) or free?

A

Tiny (<0.1%) extracellular fraction
Plasma extracellular Ca is 2.2-2.6 mmol/L
Around half is free, half is bound

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
  1. What % of the bodies phosphorus is found in bone?

- What is the remainder of phosphorus?

A

85%

Remainder is mainly intracellular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
  1. What levels fluctuate more, calcium and phosphate?
A

Phosphate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
  1. What are the clinical features of hypercalcaemia?
A

Depression, fatigue, anorexia, nausea, vomiting,
Abdominal pain, constipation
Renal calcification (kidney stones)
Bone pain
“painful bones, renal stones, abdominal groans, and psychic moans,”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
  1. What are some severe clinical features of hypercalcaemia?
A

cardiac arrhythmias, cardiac arrest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
  1. What are the most common causes of hypercalcaemia?
A

In ambulatory patients: primary hyperparathyroidism

In hospitalised patients: malignancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  1. What are the less common causes of hypercalcaemia?
A

Hyperthyroidism

Excessive intake of vitamin D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  1. What is Alkaline phosphatase?
A

. Enzyme found in liver, bone and many other tissues. In presence of bone disease may be elevated due to increased bone turnover.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
  1. What should the levels of plasma:
    -Calcium
    -Phosphate
    -Alkaline phosphatase
    -Creatinine
    -PTH
    be in a normal situation (ie the serum biochemistry)
A
  • Serum calcium - modest to marked increase
  • Serum phosphate (decreased reabsorption, increased excretion by PTH) - low or low normal.
  • Serum alkaline phosphatase raised in ~ 20% of cases due to increased bone turnover etc.
  • Serum creatinine may be elevated in longstanding disease (kidney damage)
  • Serum PTH concentration should be interpreted in relation to calcium.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
  1. If PTH is inappropriately normal and calcium levels are elevated –> What should you investigate for?
A

PTH inappropriately normal because they should be low if calcium is high
Investigate for hyperparathyroidism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
  1. Case study:
    A 52 year old woman was investigated for
    suspected kidney stones.

Serum investigations:

Total calcium	2.82 mmol/L   (2.20 - 2.52)
Phosphate 0.69 mmol/L
(0.75 - 1.50)
Albumin 42 g/L  (35 - 48)
Alkaline phosphatase 135 U/L	 (30 - 100)
PTH	 7.3 pmol/L (1 - 6.9)
Creatinine 118 mol/L (60 - 110)

Explain these results

A

Hypercalcaemia (kidney stones) due to hyperparathyroidism.

Calcium HIGH
(PTH HIGH)
(Creatinine HIGH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
  1. What is the most common cause of hypercalcaemia in hospitalised patients
    (Hypercalcaemia of malignancy)
A

o Humoral, e.g., lung carcinoma secreting PTH related Peptide which acts on PTH receptors.

o Metastatic tumour (release cytokines that promote osteoclast differentiation for bone resorption).

o Haematological: myeloma (tumour originating in the haematopoietic stem cell lineage).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

15.What is the most common cause of hypocalcaemia?

A

Vitamin D deficiency Renal failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
  1. What is a less common cause of hypocalcaemia?
A

Hypoparathyroidism

17
Q
  1. What is Rickets?
A

in children, failure of bone mineralisation of cartilaginous growth plates and disordered cartilage formation

18
Q
  1. What is osteomalacia?
A
  • in adults, impaired bone mineralisation of osteoid due to combination of low dietary intake and lack of sunlight exposure.
19
Q
  1. Who is most at risk of osteomalacia?
A

: elderly in nursing homes and not taking supplements or breast-fed babies who are kept out of sunlight.

20
Q
  1. What are some features of osteomalacia?
A

•Diffuse bone pain, waddling gait (way of walking caused by pelvic muscle weakness), muscle weakness, stress fractures (on x-rays).

21
Q
  1. What is the serum biochemistry of osteomalacia?
A

Low/normal calcium, Hypophosphataemia (should increase)

Raised alkaline phosphatase, Secondary hyperparathyroidism

22
Q
  1. What is osteoporosis?
A

health condition that weakens bones, making them fragile and more likely to break

23
Q
  1. What are some features of osteoporosis?
A

oLoss of bone mass: endocrine, malignancy, drug-induced, renal disease, nutritional.
o Loss of bone density
increased fracture risk, increase in bone resorption over formation.

24
Q
  1. Because osteoporosis is usually asymptomatic , how is one usually diagnosed with it?
A

a fragility (minor falls break bones) fracture in wrists/femur or vertebral fractures.

25
25. What are some endocrine associated causes of osteoporosis?
* Hypogonadism: especially any cause of oestrogen deficiency | * Excess endogenous or exogenous glucocorticoids, Hyperparathyroidism or Hyperthyroidism.
26
26. What is the difference between a T and Z score?
The T-score is a comparison of a person's bone density with that of a healthy 30-year-old of the same sex. Its a number (SDs) The Z-score is a comparison of a person's bone density with that of an average person of the same age and sex
27
27. How do we diagnose osteoporosis?
Measurement of bone mineral density (BMD) Dual-energy X-ray absorptiometry (DEXA or DXA scan)
28
28. In terms of T score, what would be seen in: -Normal -Osteopenia -Osteoporosis -Severe Osteoporosis ??
Normal = T-score of -1 or above Osteopenia (naturally, with age) = T-score lower than -1 and greater than -2.5 Osteoporosis =T-score of -2.5 or lower Severe osteoporosis= T-score of -2.5 or lower, and presence of at least one fragility fracture
29
29. When does bone density peak?
•Bone density peaks at 25-30 years old after which it declines, the decline is accelerated by menopause.
30
30. How is bone mass for men different to bone mass for women
higher peak of bone density due to larger mass and no accelerated decline due to no menopause.
31
31. Does the risk of osteoporosis increase with age?
Yes
32
32. What is the treatment for osteoporosis?
1. Postmenopausal: HRT (hormone replacement therapy) – effects well established but safety of long term treatment has been questioned. 2. Bisphosphonates e.g. risedronate, alendronate – inhibit function of osteoclasts. 3. PTH analogues: intermittent dose and time-dependent favour remodelling. 4. Denosumab – antibody against RANK ligand (reduced osteoclast differentiation so reduced resorption). 5. Romosozumab (approved 2019, Japan, USA, EU). - antibody against sclerostin protein so increased osteoblast differentiation. 6. Ensure adequate calcium and vit D intake, appropriate exercise.
33
33. What is the brief history of HRT? | * I dont know if we need to know this guys:) *
* 1947. US approves Premarin (conjugated equine oestrogen: PREgnant MAre's urINe) treatment of hot flushes * 1966. Feminine Forever by gynaecologist Robert Wilson promoting HRT as lifestyle choice * 1970s. Strong association between oestrogen therapy and endometrial cancer so HRT (oestrogen only) use declines. * 1980s. Combination HRT products (progestins added to counter proliferative effects of unopposed oestrogen on endometrium) use rises again (oestrogen-progesterone). * Preventative effect on BMD, osteoporosis and other claimed benefits: e.g., CV protection – evidence from experimental literature, but no large RCTs (randomised control trials). * HRT use peaks late 1990s (15 M women in USA)
34
34 . Which randomised controlled trial took place for HRT?
o Women's Health Initiative (WHI) in USA,, Million Women Study in UK, 2002 preliminary results from WHI published o No CV protective effects (possibly the reverse). o Claimed significantly increased breast cancer risk followed by years of controversy and debate
35
35 . What were the Overall Effects from WHI: % of women per year (all ages):
* Fracture risks reduced massively with hormone replacement therapy. * Cancer risk reduced with just oestrogen but increased with oestrogen-progesterone combined therapy.
36
36. What is relative risk versus absolute risk?
If something you do triples your risk, then your relative risk increases 300%. Absolute risk is the size of your own risk (Media quotes only relative risk without absolute risk--> Can be misleading)
37
37. What were further analysis of the WHI results? | - How were the guidelines for HRT modified because of this
• The original WHI participants were older, post-menopausal women (mean age of 64 and 10 years post-menopause). • Separate analysis of <10 or >10 yrs post-menopause suggested risks were reduced in earlier group. • Guidelines for HRT modified: o Short-term therapy (3-5 years) for treating vasomotor (blood pressure) symptoms. o Lowest effective dose is to be used and long term use is not recommended.
38
38 . What do the NICE guidelines for HRT in 2015 state?
- > HRT is the most effective treatment for relief of vasomotor symptoms although other options, including non-pharmacological ones are available - > For most symptomatic. menopausal women, the benefits of HRT outweigh the risks
39
39. Give an overview of the signal networks in bone remodelling?
* Osteocytes detect small/minor stress fractures and cause osteoclast recruitment, proliferation, differentiation. * Activated osteoclasts result in bone resorption (digestion and release of minerals) before they die by apoptosis. * Osteoblasts are recruited to the area of resorbed bone and they replace it with osteoid which is then mineralised.